These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19095344)

  • 41. Carcinoma of prostate treated with oestrogens.
    FERGUSSON JD
    Lancet; 1946 Oct; 2(6425):551-6. PubMed ID: 21001706
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prostate cancer].
    Matousková M
    Klin Onkol; 2008; 21(5):280-7. PubMed ID: 19202959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do estrogens impact adolescent idiopathic scoliosis?
    Leboeuf D; Letellier K; Alos N; Edery P; Moldovan F
    Trends Endocrinol Metab; 2009 May; 20(4):147-52. PubMed ID: 19349194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
    Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer.
    Hess-Wilson JK
    Cancer Causes Control; 2009 Sep; 20(7):1029-37. PubMed ID: 19370395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reaction to 'Sensitive to change: neuroendocrinologic aspects of depression in women'].
    Otter M
    Tijdschr Psychiatr; 2007; 49(9):675-6. PubMed ID: 17853378
    [No Abstract]   [Full Text] [Related]  

  • 47. Some observations on carcinoma of the prostate treated with oestrogens, as demonstrated by serial biopsies.
    FERGUSSON JD; PAGEL W
    Br J Surg; 1945 Oct; 33():122-30. PubMed ID: 21009351
    [No Abstract]   [Full Text] [Related]  

  • 48. Estrogen signaling pathway and its imaging in human breast cancer.
    Hayashi S; Niwa T; Yamaguchi Y
    Cancer Sci; 2009 Oct; 100(10):1773-8. PubMed ID: 19575750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re: Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.
    Ghani KR; Oliver RT; Chinegwundoh F
    BJU Int; 2009 Jan; 103(2):270-1; author reply 271. PubMed ID: 19278533
    [No Abstract]   [Full Text] [Related]  

  • 51. Special issue: prostate cancer. Introduction.
    Bissada NK
    J S C Med Assoc; 1994 May; 90(5):209. PubMed ID: 8028289
    [No Abstract]   [Full Text] [Related]  

  • 52. [Mastectomy in cancer of the prostate].
    MAZUREK L
    Urol Pol; 1956; 9():103-6. PubMed ID: 13401614
    [No Abstract]   [Full Text] [Related]  

  • 53. [Present-day hypotheses of prostatic cancer etiology and pathogenesis].
    Gubanov ES; Prianichkova MB
    Urologiia; 2004; (5):72-6. PubMed ID: 15560172
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
    Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
    Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Secondary endocrine therapy with oral estrogen for relapsed prostate cancer].
    Onita T; Igawa T; Hisamatsu H; Sakai H; Kanetake H
    Hinyokika Kiyo; 2009 Oct; 55(10):595-8. PubMed ID: 19926941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
    Lu Y
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel secondary hormonal therapy in advanced prostate cancer: an update.
    Van Allen EM; Ryan CJ
    Curr Opin Urol; 2009 May; 19(3):315-21. PubMed ID: 19342958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.
    Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S
    Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifunctional nanoparticles for prostate cancer therapy.
    Salvador-Morales C; Gao W; Ghatalia P; Murshed F; Aizu W; Langer R; Farokhzad OC
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):211-21. PubMed ID: 19192959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.